United States Ophthalmic Drugs Market Report 2018


Report ID : RC-1545 Category : Healthcare Published Date : Oct-18
Publisher : S-AND-P Pages : 113 Format : PDF
In this report, the United States Ophthalmic Drugs market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Ophthalmic Drugs in these regions, from 2012 to 2023 (forecast).

United States Ophthalmic Drugs market competition by top manufacturers/players, with Ophthalmic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Merck
    Glaxosmithkline
    Abbott Laboratories
    Johnson and Johnson
    Bayer
    Roche Holding
    Novartis
    Akorn
    Eyemed
    Senju Pharmaceutical
    Sun Pharmaceuticals Industries
    Allergan
    Valeant
    Regeneron
    Eyegate Pharmaceuticals
    Lpath Incorporated
    Santen Pharmaceutical
    Cipla Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Solutions
    Ointments
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Ophthalmic Drugs for each application, including
    Hospitals
    Eye Clinics
    Diagnostic Centers
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.
United States Ophthalmic Drugs Market Report 2018
1 Ophthalmic Drugs Overview
    1.1 Product Overview and Scope of Ophthalmic Drugs
    1.2 Classification of Ophthalmic Drugs by Product Category
        1.2.1 United States Ophthalmic Drugs Market Size (Sales Volume) Comparison by Type (2012-2023)
        1.2.2 United States Ophthalmic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2018
        1.2.3 Solutions
        1.2.4 Ointments
        1.2.5 Other
    1.3 United States Ophthalmic Drugs Market by Application/End Users
        1.3.1 United States Ophthalmic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2023)
        1.3.2 Hospitals
        1.3.3 Eye Clinics
        1.3.4 Diagnostic Centers
        1.3.5 Other
    1.4 United States Ophthalmic Drugs Market by Region
        1.4.1 United States Ophthalmic Drugs Market Size (Value) Comparison by Region (2012-2023)
        1.4.2 The West Ophthalmic Drugs Status and Prospect (2012-2023)
        1.4.3 Southwest Ophthalmic Drugs Status and Prospect (2012-2023)
        1.4.4 The Middle Atlantic Ophthalmic Drugs Status and Prospect (2012-2023)
        1.4.5 New England Ophthalmic Drugs Status and Prospect (2012-2023)
        1.4.6 The South Ophthalmic Drugs Status and Prospect (2012-2023)
        1.4.7 The Midwest Ophthalmic Drugs Status and Prospect (2012-2023)
    1.5 United States Market Size (Value and Volume) of Ophthalmic Drugs (2012-2023)
        1.5.1 United States Ophthalmic Drugs Sales and Growth Rate (2012-2023)
        1.5.2 United States Ophthalmic Drugs Revenue and Growth Rate (2012-2023)

2 United States Ophthalmic Drugs Market Competition by Players/Suppliers
    2.1 United States Ophthalmic Drugs Sales and Market Share of Key Players/Suppliers (2012-2018)
    2.2 United States Ophthalmic Drugs Revenue and Share by Players/Suppliers (2012-2018)
    2.3 United States Ophthalmic Drugs Average Price by Players/Suppliers (2012-2018)
    2.4 United States Ophthalmic Drugs Market Competitive Situation and Trends
        2.4.1 United States Ophthalmic Drugs Market Concentration Rate
        2.4.2 United States Ophthalmic Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Ophthalmic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Ophthalmic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2018)
    3.1 United States Ophthalmic Drugs Sales and Market Share by Region (2012-2018)
    3.2 United States Ophthalmic Drugs Revenue and Market Share by Region (2012-2018)
    3.3 United States Ophthalmic Drugs Price by Region (2012-2018)

4 United States Ophthalmic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2018)
    4.1 United States Ophthalmic Drugs Sales and Market Share by Type (Product Category) (2012-2018)
    4.2 United States Ophthalmic Drugs Revenue and Market Share by Type (2012-2018)
    4.3 United States Ophthalmic Drugs Price by Type (2012-2018)
    4.4 United States Ophthalmic Drugs Sales Growth Rate by Type (2012-2018)

5 United States Ophthalmic Drugs Sales (Volume) by Application (2012-2018)
    5.1 United States Ophthalmic Drugs Sales and Market Share by Application (2012-2018)
    5.2 United States Ophthalmic Drugs Sales Growth Rate by Application (2012-2018)
    5.3 Market Drivers and Opportunities

6 United States Ophthalmic Drugs Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ophthalmic Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.1.4 Main Business/Business Overview
    6.2 Merck
        6.2.2 Ophthalmic Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.2.4 Main Business/Business Overview
    6.3 Glaxosmithkline
        6.3.2 Ophthalmic Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Glaxosmithkline Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.3.4 Main Business/Business Overview
    6.4 Abbott Laboratories
        6.4.2 Ophthalmic Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abbott Laboratories Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.4.4 Main Business/Business Overview
    6.5 Johnson and Johnson
        6.5.2 Ophthalmic Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Johnson and Johnson Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.5.4 Main Business/Business Overview
    6.6 Bayer
        6.6.2 Ophthalmic Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bayer Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.6.4 Main Business/Business Overview
    6.7 Roche Holding
        6.7.2 Ophthalmic Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Roche Holding Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.7.4 Main Business/Business Overview
    6.8 Novartis
        6.8.2 Ophthalmic Drugs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Novartis Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.8.4 Main Business/Business Overview
    6.9 Akorn
        6.9.2 Ophthalmic Drugs Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Akorn Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.9.4 Main Business/Business Overview
    6.10 Eyemed
        6.10.2 Ophthalmic Drugs Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Eyemed Ophthalmic Drugs Sales, Revenue, Price and Gross Margin (2012-2018)
        6.10.4 Main Business/Business Overview
    6.11 Senju Pharmaceutical
    6.12 Sun Pharmaceuticals Industries
    6.13 Allergan
    6.14 Valeant
    6.15 Regeneron
    6.16 Eyegate Pharmaceuticals
    6.17 Lpath Incorporated
    6.18 Santen Pharmaceutical
    6.19 Cipla Pharmaceuticals

7 Ophthalmic Drugs Manufacturing Cost Analysis
    7.1 Ophthalmic Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ophthalmic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ophthalmic Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ophthalmic Drugs Major Manufacturers in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Ophthalmic Drugs Market Size (Value and Volume) Forecast (2018-2023)
    11.1 United States Ophthalmic Drugs Sales Volume, Revenue Forecast (2018-2023)
    11.2 United States Ophthalmic Drugs Sales Volume Forecast by Type (2018-2023)
    11.3 United States Ophthalmic Drugs Sales Volume Forecast by Application (2018-2023)
    11.4 United States Ophthalmic Drugs Sales Volume Forecast by Region (2018-2023)

12 Research Findings and Conclusion

Sidebar Menu